The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Nuvalent Inc shares valued at $2,289,840 were purchased by DEBORAH MILLER on Jan 22 ’26. At $109.04 per share, DEBORAH MILLER acquired 21,000 shares.
Also, Pelish Henry E. sold 2,664 shares, netting a total of over 258,848 in proceeds. Following the sale of shares at $97.17 each, the insider now holds 65,888 shares.
Before that, Pelish Henry E. had sold 2,496 shares from its account. In a trade valued at $242,905, the Chief Scientific Officer traded Nuvalent Inc shares for $97.32 each. Upon closing the transaction, the insider’s holdings decreased to 2,496 shares, worth approximately $7.68 million.
As published in their initiating research note from Truist on November 24, 2025, Nuvalent Inc [NUVL] has been a Buy. Analysts at Canaccord Genuity started covering the stock with ‘”a Buy”‘ outlook in a report released in mid November. Earlier on October 15, 2025, Cantor Fitzgerald initiated its rating. Their recommendation was “an Overweight” for NUVL stock.
Analyzing NUVL Stock Performance
On last trading session, Nuvalent Inc [NASDAQ: NUVL] rose 2.71% to $111.99. The stock’s lowest price that day was $105.3, but it reached a high of $113.015 in the same session. During the last five days, there has been a surge of approximately 3.85%. Over the course of the year, Nuvalent Inc shares have jumped approximately 43.06%.
Is Nuvalent Inc subject to short interest?
Stocks of Nuvalent Inc saw a sharp rise in short interest on 2025-12-31 jumping by 0.72 million shares to 5.46 million. Data from Yahoo Finance shows that the short interest on 2025-11-28 was 4.74 million shares. A jump of 13.15% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 10.75 of the overall float, the days-to-cover ratio (short ratio) jumped to 10.75.
Which companies own the most shares of Nuvalent Inc (NUVL)?
In terms of Nuvalent Inc share price expectations, FactSet research, analysts set an average price target of 132 in the next 12 months, up nearly 21.06% from the previous closing price of $109.04. Analysts anticipate Nuvalent Inc stock to reach 155 by 2026, with the lowest price target being 105. In spite of this, 2 analysts ranked Nuvalent Inc stock as Buy at the end of 2026. On September 04, 2025, Guggenheim assigned a price target of “a Buy” to the stock and resumed coverage with a $122.
